SCHEMBL6860941

SCHEMBL6860941

C=C(C)C(=O)OCCCCCCCCCCCCCCCC[n+]1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.56
POLB P06746 1/20 0.50
APEX1 P27695 1/20 0.50
HTT P42858 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
MEN1 O00255 1/20 0.47
MAPT P10636 1/20 0.47
MAPK1 P28482 1/20 0.47
CASP2 P42575 1/20 0.47
KMT2A Q03164 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
BCHE P06276 3/20 0.47
ACHE P22303 2/20 0.47
HSPD1 P10809 1/20 0.46
RAD52 P43351 1/20 0.46
HSPE1 P61604 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7055391 1.00 TSHR (0.56) TSHRPOLBAPEX1HTTTDP1
Hydrochloric Acid SCHEMBL1032458 1.00 TSHR (0.56) TSHRPOLBAPEX1HTTTDP1
SCHEMBL6397609 1.00 TSHR (0.56) TSHRPOLBAPEX1HTTTDP1
Hydrochloric Acid SCHEMBL346360 1.00 TSHR (0.56) TSHRPOLBAPEX1HTTTDP1
Hydrochloric Acid SCHEMBL9132796 1.00 TSHR (0.56) TSHRPOLBAPEX1HTTTDP1
Bromide SCHEMBL7058976 0.98 TSHR (0.54) TSHRPOLBAPEX1HTTTDP1
Bromide SCHEMBL7056467 0.98 TSHR (0.54) TSHRPOLBAPEX1HTTTDP1
Bromide SCHEMBL31748172 0.98 TSHR (0.54) TSHRPOLBAPEX1HTTTDP1
Bromide SCHEMBL345541 0.98 TSHR (0.54) TSHRPOLBAPEX1HTTTDP1
Bromide SCHEMBL31748176 0.98 TSHR (0.54) TSHRPOLBAPEX1HTTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230055449-A1 FUNCTIONAL SURFACES ORTHOBOND CORP (US) 2023-02-23 US claimed
EP-3525776-B1 SURFACES WITH OLIGOMERIC OR POLYMERIC ANTIMICROBIALS ORTHOBOND CORP (US) 2022-01-26 EP claimed
CN-110312507-B Surfaces with oligomeric or polymeric antimicrobial agents 奥索邦德公司 2021-11-23 CN claimed
US-20210352903-A1 FUNCTIONAL SURFACES ORTHOBOND CORP (US) 2021-11-18 US claimed
US-11154061-B2 Functional surfaces Orthobond Corporation (US) 2021-10-26 US claimed
US-10390533-B2 Surfaces with oligomeric or polymeric antimicrobials Orthobond Corporation (US) 2019-08-27 US claimed
EP-3525776-A1 SURFACES WITH OLIGOMERIC OR POLYMERIC ANTIMICROBIALS Orthobond Corporation (US) 2019-08-21 EP claimed
WO-2018075457-A1 SURFACES WITH OLIGOMERIC OR POLYMERIC ANTIMICROBIALS Orthobond Corporation (US) 2018-04-26 WO claimed
US-20180103642-A1 Surfaces with Oligomeric or Polymeric Antimicrobials Orthobond Corporation 2018-04-19 US claimed
US-20180103643-A1 Functional Surfaces Orthobond Corporation 2018-04-19 US claimed
US-6355704-B1 BACTERICIDE PRIMERS; BONDING TO TEETH KURARAY CO., LTD. (JP) 2002-03-12 US claimed
US-20230055449-A1 FUNCTIONAL SURFACES ORTHOBOND CORP (US) 2023-02-23 US disclosed
WO-2022182713-A1 METHODS OF PHOTOGRAFTING TO SURFACE METAL OXIDES Orthobond Corporation (US) 2022-09-01 WO disclosed
US-20220266296-A1 Methods of Photografting to Surface Metal Oxides Orthobond Corporation 2022-08-25 US disclosed
EP-3525776-B1 SURFACES WITH OLIGOMERIC OR POLYMERIC ANTIMICROBIALS ORTHOBOND CORP (US) 2022-01-26 EP disclosed
EP-0980682-B1 Bonding compositions for dental use KURARAY CO (JP) 2003-11-05 EP disclosed
CN-1386132-A antibacterial composition KURARAY CO (JP) 2002-12-18 CN disclosed
US-20020035169-A1 Bonding compositions for dental use KURARAY CO., LTD (JP) 2002-03-21 US disclosed
US-6355704-B1 BACTERICIDE PRIMERS; BONDING TO TEETH KURARAY CO., LTD. (JP) 2002-03-12 US disclosed
EP-0980682-A1 Bonding compositions for dental use KURARAY CO., LTD. (JP) 2000-02-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020035169-A1 Bonding compositions for dental use PTK2, DEK, POLK TSHR 4726/4885POLB 39/4885APEX1 586/4885
US-20180103642-A1 Surfaces with Oligomeric or Polymeric Antimicrobials PICALM, NONO, LPO TSHR 1455/4885POLB 1274/4885APEX1 279/4885
US-20230055449-A1 FUNCTIONAL SURFACES LPO, SELP, SIGLEC7 TSHR 2514/4885POLB 2915/4885APEX1 241/4885
US-11154061-B2 Functional surfaces LPO, SELP, SIGLEC7 TSHR 2514/4885POLB 2915/4885APEX1 241/4885
US-20210352903-A1 FUNCTIONAL SURFACES LPO, SELP, SIGLEC7 TSHR 2514/4885POLB 2915/4885APEX1 241/4885
US-10390533-B2 Surfaces with oligomeric or polymeric antimicrobials PICALM, NONO, LPO TSHR 1455/4885POLB 1274/4885APEX1 279/4885
US-20180103643-A1 Functional Surfaces LPO, SELP, SIGLEC7 TSHR 2514/4885POLB 2915/4885APEX1 241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.